标题
Big opportunities for small molecules in immuno-oncology
作者
关键词
-
出版物
NATURE REVIEWS DRUG DISCOVERY
Volume 14, Issue 9, Pages 603-622
出版商
Springer Nature
发表日期
2015-07-31
DOI
10.1038/nrd4596
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Tadalafil Augments Tumor Specific Immunity in Patients with Head and Neck Squamous Cell Carcinoma
- (2015) J. A. Califano et al. CLINICAL CANCER RESEARCH
- The BRAF and MEK Inhibitors Dabrafenib and Trametinib: Effects on Immune Function and in Combination with Immunomodulatory Antibodies Targeting PD-1, PD-L1, and CTLA-4
- (2015) L. Liu et al. CLINICAL CANCER RESEARCH
- Abstract 5023: Synergistic antitumor effects of combinatorial immune checkpoint inhibition with anti-PD-1/PD-L antibodies and the IDO pathway inhibitors NLG-919 and indoximod in the context of active immunotherapy
- (2015) Mario R. Mautino et al. CANCER RESEARCH
- Blockade of A2b Adenosine Receptor Reduces Tumor Growth and Immune Suppression Mediated by Myeloid-Derived Suppressor Cells in a Mouse Model of Melanoma
- (2015) Raffaella Iannone et al. NEOPLASIA
- Directing the Immune System with Chemical Compounds
- (2014) Rock J. Mancini et al. ACS Chemical Biology
- Human CD4+CD39+regulatory T cells produce adenosine upon co-expression of surface CD73 or contact with CD73+exosomes or CD73+cells
- (2014) P. J. Schuler et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Tadalafil Reduces Myeloid-Derived Suppressor Cells and Regulatory T Cells and Promotes Tumor Immunity in Patients with Head and Neck Squamous Cell Carcinoma
- (2014) D. T. Weed et al. CLINICAL CANCER RESEARCH
- A Phase I Dose-Finding Study of the Novel Toll-like Receptor 8 Agonist VTX-2337 in Adult Subjects with Advanced Solid Tumors or Lymphoma
- (2014) D. W. Northfelt et al. CLINICAL CANCER RESEARCH
- First-in-Human Dose Study of the Novel Transforming Growth Factor-β Receptor I Kinase Inhibitor LY2157299 Monohydrate in Patients with Advanced Cancer and Glioma
- (2014) Jordi Rodon et al. CLINICAL CANCER RESEARCH
- Inhibition of Tumor-Derived Prostaglandin-E2 Blocks the Induction of Myeloid-Derived Suppressor Cells and Recovers Natural Killer Cell Activity
- (2014) Y. Mao et al. CLINICAL CANCER RESEARCH
- Pembrolizumab: First Global Approval
- (2014) Raewyn M. Poole DRUGS
- Induced regulatory T cells in inhibitory microenvironments created by cancer
- (2014) Theresa L Whiteside EXPERT OPINION ON BIOLOGICAL THERAPY
- Going viral: chimeric antigen receptor T-cell therapy for hematological malignancies
- (2014) Saar Gill et al. IMMUNOLOGICAL REVIEWS
- Targeting regulatory T cells in tumor immunotherapy
- (2014) Mark J Smyth et al. IMMUNOLOGY AND CELL BIOLOGY
- Discovery of N-((4-([1,2,4]Triazolo[1,5-a]pyridin-6-yl)-5-(6-methylpyridin-2-yl)-1H-imidazol-2-yl)methyl)-2-fluoroaniline (EW-7197): A Highly Potent, Selective, and Orally Bioavailable Inhibitor of TGF-β Type I Receptor Kinase as Cancer Immunotherapeutic/Antifibrotic Agent
- (2014) Cheng Hua Jin et al. JOURNAL OF MEDICINAL CHEMISTRY
- Idelalisib—targeting PI3Kδ in patients with B-cell malignancies
- (2014) Jan A. Burger et al. Nature Reviews Clinical Oncology
- Therapeutic vaccines for cancer: an overview of clinical trials
- (2014) Ignacio Melero et al. Nature Reviews Clinical Oncology
- Amino Acids and Immune Response: A Role for Cysteine, Glutamine, Phenylalanine, Tryptophan and Arginine in T-cell Function and Cancer?
- (2014) Angelos K. Sikalidis PATHOLOGY & ONCOLOGY RESEARCH
- Tumor Mouse Model Confirms MAGE-A3 Cancer Immunotherapeutic As an Efficient Inducer of Long-Lasting Anti-Tumoral Responses
- (2014) Catherine Gérard et al. PLoS One
- Disruption of CXCR2-Mediated MDSC Tumor Trafficking Enhances Anti-PD1 Efficacy
- (2014) S. L. Highfill et al. Science Translational Medicine
- ATP/P2X7 axis modulates myeloid-derived suppressor cell functions in neuroblastoma microenvironment
- (2014) G Bianchi et al. Cell Death & Disease
- In Vitro Characterization of the Anti-PD-1 Antibody Nivolumab, BMS-936558, and In Vivo Toxicology in Non-Human Primates
- (2014) C. Wang et al. Cancer Immunology Research
- Cardiovascular toxicity and titin cross-reactivity of affinity-enhanced T cells in myeloma and melanoma
- (2013) G. P. Linette et al. BLOOD
- Intratumoral regulatory T cells upregulate immunosuppressive molecules in head and neck cancer patients
- (2013) H-B Jie et al. BRITISH JOURNAL OF CANCER
- 8-BuS-ATP derivatives as specific NTPDase1 inhibitors
- (2013) Joanna Lecka et al. BRITISH JOURNAL OF PHARMACOLOGY
- CXCR2-Expressing Myeloid-Derived Suppressor Cells Are Essential to Promote Colitis-Associated Tumorigenesis
- (2013) Hiroshi Katoh et al. CANCER CELL
- The chemokine system, and its CCR5 and CXCR4 receptors, as potential targets for personalized therapy in cancer
- (2013) Polina Weitzenfeld et al. CANCER LETTERS
- TLR4 is essential for dendritic cell activation and anti-tumor T-cell response enhancement by DAMPs released from chemically stressed cancer cells
- (2013) Hongliang Fang et al. Cellular & Molecular Immunology
- The Intersection of Immune-Directed and Molecularly Targeted Therapy in Advanced Melanoma: Where We Have Been, Are, and Will Be
- (2013) R. J. Sullivan et al. CLINICAL CANCER RESEARCH
- The High-Affinity CXCR4 Antagonist BKT140 Is Safe and Induces a Robust Mobilization of Human CD34+ Cells in Patients with Multiple Myeloma
- (2013) A. Peled et al. CLINICAL CANCER RESEARCH
- Inflammatory Monocyte Mobilization Decreases Patient Survival in Pancreatic Cancer: A Role for Targeting the CCL2/CCR2 Axis
- (2013) D. E. Sanford et al. CLINICAL CANCER RESEARCH
- BRAF Inhibition Is Associated with Enhanced Melanoma Antigen Expression and a More Favorable Tumor Microenvironment in Patients with Metastatic Melanoma
- (2013) D. T. Frederick et al. CLINICAL CANCER RESEARCH
- Activin receptor-like kinase5 inhibition suppresses mouse melanoma by ubiquitin degradation of Smad4, thereby derepressing eomesodermin in cytotoxic T lymphocytes
- (2013) Jeong-Hwan Yoon et al. EMBO Molecular Medicine
- Myeloid derived suppressor cells in physiological and pathological conditions: the good, the bad, and the ugly
- (2013) Paolo Serafini IMMUNOLOGIC RESEARCH
- Vemurafenib reverses immunosuppression by myeloid derived suppressor cells
- (2013) Bastian Schilling et al. INTERNATIONAL JOURNAL OF CANCER
- Depleting tumor-specific Tregs at a single site eradicates disseminated tumors
- (2013) Aurélien Marabelle et al. JOURNAL OF CLINICAL INVESTIGATION
- Interferon-dependent IL-10 production by Tregs limits tumor Th17 inflammation
- (2013) C. Andrew Stewart et al. JOURNAL OF CLINICAL INVESTIGATION
- STAT inhibitors for cancer therapy
- (2013) Muhammad Furqan et al. Journal of Hematology & Oncology
- TLR agonists: our best frenemy in cancer immunotherapy
- (2013) Sabina Kaczanowska et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Toll-like Receptor 4 (TLR4) Modulation by Synthetic and Natural Compounds: An Update
- (2013) Francesco Peri et al. JOURNAL OF MEDICINAL CHEMISTRY
- Discovery of (R)-2-Amino-6-borono-2-(2-(piperidin-1-yl)ethyl)hexanoic Acid and Congeners As Highly Potent Inhibitors of Human Arginases I and II for Treatment of Myocardial Reperfusion Injury
- (2013) Michael C. Van Zandt et al. JOURNAL OF MEDICINAL CHEMISTRY
- Targeting the hypoxia-adenosinergic signaling pathway to improve the adoptive immunotherapy of cancer
- (2013) Michail Sitkovsky et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Therapeutic Potentials of Ecto-Nucleoside Triphosphate Diphosphohydrolase, Ecto-Nucleotide Pyrophosphatase/Phosphodiesterase, Ecto-5′-Nucleotidase, and Alkaline Phosphatase Inhibitors
- (2013) Mariya al-Rashida et al. MEDICINAL RESEARCH REVIEWS
- CSF-1R inhibition alters macrophage polarization and blocks glioma progression
- (2013) Stephanie M Pyonteck et al. NATURE MEDICINE
- Adenosine receptors as drug targets — what are the challenges?
- (2013) Jiang-Fan Chen et al. NATURE REVIEWS DRUG DISCOVERY
- Synergy between the ectoenzymes CD39 and CD73 contributes to adenosinergic immunosuppression in human malignant gliomas
- (2013) Shuo Xu et al. NEURO-ONCOLOGY
- Hepatotoxicity with Combination of Vemurafenib and Ipilimumab
- (2013) Antoni Ribas et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Yin and Yang of Toll-like receptors in cancer
- (2013) J-P Pradere et al. ONCOGENE
- P2X7 Integrates PI3K/AKT and AMPK-PRAS40-mTOR Signaling Pathways to Mediate Tumor Cell Death
- (2013) Shu Bian et al. PLoS One
- Blockade of A2Areceptors potently suppresses the metastasis of CD73+tumors
- (2013) Paul A. Beavis et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Targeting CXCL12 from FAP-expressing carcinoma-associated fibroblasts synergizes with anti-PD-L1 immunotherapy in pancreatic cancer
- (2013) C. Feig et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- ‘Cancer associated fibroblasts’ – more than meets the eye
- (2013) Shalom Madar et al. TRENDS IN MOLECULAR MEDICINE
- Small Molecule Inhibitors of CXCR4
- (2013) Bikash Debnath et al. Theranostics
- Adenosine and Prostaglandin E2 Production by Human Inducible Regulatory T Cells in Health and Disease
- (2013) Theresa L. Whiteside et al. Frontiers in Immunology
- Natural and Induced T Regulatory Cells in Cancer
- (2013) Dennis O. Adeegbe et al. Frontiers in Immunology
- A prostaglandin E (PGE) receptor EP4 antagonist protects natural killer cells from PGE2-mediated immunosuppression and inhibits breast cancer metastasis
- (2013) Xinrong Ma et al. OncoImmunology
- RON promotes the metastatic spread of breast carcinomas by subverting antitumor immune responses
- (2013) Henok Eyob et al. OncoImmunology
- Immunogenic Cell Death in Cancer Therapy
- (2012) Guido Kroemer et al. Annual Review of Immunology
- The Role of Anti-Inflammatory Drugs in Colorectal Cancer
- (2012) Dingzhi Wang et al. Annual Review of Medicine
- Expression of P2X7 Receptor Increases In Vivo Tumor Growth
- (2012) E. Adinolfi et al. CANCER RESEARCH
- Role of Chemokines and Chemokine Receptors in Shaping the Effector Phase of the Antitumor Immune Response
- (2012) K. Franciszkiewicz et al. CANCER RESEARCH
- Oncogenic BRAF(V600E) Promotes Stromal Cell-Mediated Immunosuppression Via Induction of Interleukin-1 in Melanoma
- (2012) J. S. Khalili et al. CLINICAL CANCER RESEARCH
- A beginner’s guide to chemokines
- (2012) Victoria Vinader et al. Future Medicinal Chemistry
- The emerging role of CXC chemokines and their receptors in cancer
- (2012) Victoria Vinader et al. Future Medicinal Chemistry
- Stat3 and Gfi-1 Transcription Factors Control Th17 Cell Immunosuppressive Activity via the Regulation of Ectonucleotidase Expression
- (2012) Fanny Chalmin et al. IMMUNITY
- The Chemokine Superfamily Revisited
- (2012) Albert Zlotnik et al. IMMUNITY
- Ipilimumab in Combination With Paclitaxel and Carboplatin As First-Line Treatment in Stage IIIB/IV Non–Small-Cell Lung Cancer: Results From a Randomized, Double-Blind, Multicenter Phase II Study
- (2012) Thomas J. Lynch et al. JOURNAL OF CLINICAL ONCOLOGY
- Inhibition of CD73 Improves B Cell-Mediated Anti-Tumor Immunity in a Mouse Model of Melanoma
- (2012) G. Forte et al. JOURNAL OF IMMUNOLOGY
- Incyte comes of age with JAK inhibitor approval
- (2012) Nuala Moran NATURE BIOTECHNOLOGY
- The secret ally: immunostimulation by anticancer drugs
- (2012) Lorenzo Galluzzi et al. NATURE REVIEWS DRUG DISCOVERY
- ENTPD1/CD39 is a promising therapeutic target in oncology
- (2012) J Bastid et al. ONCOGENE
- Reversal of tumoral immune resistance by inhibition of tryptophan 2,3-dioxygenase
- (2012) L. Pilotte et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Crystal Structure of the Human Ecto-5′-Nucleotidase (CD73): Insights into the Regulation of Purinergic Signaling
- (2012) Karen Knapp et al. STRUCTURE
- Pre-emptive plerixafor injection increases blood neutrophil, lymphocyte and monocyte counts in addition to CD34+ counts in patients with non-Hodgkin lymphoma mobilizing poorly with chemotherapy plus G-CSF: Potential implications for apheresis and graft composition
- (2012) V. Varmavuo et al. TRANSFUSION AND APHERESIS SCIENCE
- The development and immunosuppressive functions of CD4+ CD25+ FoxP3+ regulatory T cells are under influence of the adenosine-A2A adenosine receptor pathway
- (2012) Akio Ohta et al. Frontiers in Immunology
- Subversion of the chemotherapy-induced anticancer immune response by the ecto-ATPase CD39
- (2012) Mickaël Michaud et al. OncoImmunology
- Expression patterns of the immunomodulatory enzyme arginase 1 in blood, lymph nodes and tumor tissue of early-stage breast cancer patients
- (2012) Jana de Boniface et al. OncoImmunology
- Positive feedback between PGE2 and COX2 redirects the differentiation of human dendritic cells toward stable myeloid-derived suppressor cells
- (2011) N. Obermajer et al. BLOOD
- CD73-generated extracellular adenosine in chronic lymphocytic leukemia creates local conditions counteracting drug-induced cell death
- (2011) S. Serra et al. BLOOD
- In vitro and in vivo characterization of PF-04418948, a novel, potent and selective prostaglandin EP2 receptor antagonist
- (2011) KJ af Forselles et al. BRITISH JOURNAL OF PHARMACOLOGY
- Improving cancer immunotherapy by targeting tumor-induced immune suppression
- (2011) Trina J. Stewart et al. CANCER AND METASTASIS REVIEWS
- Receptor Tyrosine Kinases and TLR/IL1Rs Unexpectedly Activate Myeloid Cell PI3Kγ, A Single Convergent Point Promoting Tumor Inflammation and Progression
- (2011) Michael C. Schmid et al. CANCER CELL
- Prostaglandin E2 (PGE2) suppresses natural killer cell function primarily through the PGE2 receptor EP4
- (2011) Dawn Holt et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- COX-2 inhibition alters the phenotype of tumor-associated macrophages from M2 to M1 in ApcMin/+ mouse polyps
- (2011) Y. Nakanishi et al. CARCINOGENESIS
- PROVENGE (Sipuleucel-T) in Prostate Cancer: The First FDA-Approved Therapeutic Cancer Vaccine
- (2011) M. A. Cheever et al. CLINICAL CANCER RESEARCH
- Adenosine promotes alternative macrophage activation via A2A and A2B receptors
- (2011) Balázs Csóka et al. FASEB JOURNAL
- CD73 has distinct roles in nonhematopoietic and hematopoietic cells to promote tumor growth in mice
- (2011) Long Wang et al. JOURNAL OF CLINICAL INVESTIGATION
- Chemokine nitration prevents intratumoral infiltration of antigen-specific T cells
- (2011) Barbara Molon et al. JOURNAL OF EXPERIMENTAL MEDICINE
- The pharmacological effect of BGC20-1531, a novel prostanoid EP4 receptor antagonist, in the Prostaglandin E2 human model of headache
- (2011) Maria Antonova et al. JOURNAL OF HEADACHE AND PAIN
- Cancer Exosomes Express CD39 and CD73, Which Suppress T Cells through Adenosine Production
- (2011) A. Clayton et al. JOURNAL OF IMMUNOLOGY
- Adenosinergic Regulation of the Expansion and Immunosuppressive Activity of CD11b+Gr1+ Cells
- (2011) S. Ryzhov et al. JOURNAL OF IMMUNOLOGY
- Adenosine A2B Receptor Blockade Slows Growth of Bladder and Breast Tumors
- (2011) C. Cekic et al. JOURNAL OF IMMUNOLOGY
- An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor
- (2011) Christiane A. Opitz et al. NATURE
- A methodological framework to enhance the clinical success of cancer immunotherapy
- (2011) Axel Hoos et al. NATURE BIOTECHNOLOGY
- Imatinib potentiates antitumor T cell responses in gastrointestinal stromal tumor through the inhibition of Ido
- (2011) Vinod P Balachandran et al. NATURE MEDICINE
- ATP Inhibits the Generation and Function of Regulatory T Cells Through the Activation of Purinergic P2X Receptors
- (2011) U. Schenk et al. Science Signaling
- Induction of Heart Valve Lesions by Small-Molecule ALK5 Inhibitors
- (2011) Mark J. Anderton et al. TOXICOLOGIC PATHOLOGY
- Leukocyte Complexity Predicts Breast Cancer Survival and Functionally Regulates Response to Chemotherapy
- (2011) David G. DeNardo et al. Cancer Discovery
- Cytokines in Cancer Immunotherapy
- (2011) Sylvia Lee et al. Cancers
- Selective inhibition of IDO1 effectively regulates mediators of antitumor immunity
- (2010) X. Liu et al. BLOOD
- Immunity, Inflammation, and Cancer
- (2010) Sergei I. Grivennikov et al. CELL
- CD39/ENTPD1 Expression by CD4+Foxp3+ Regulatory T Cells Promotes Hepatic Metastatic Tumor Growth in Mice
- (2010) Xiaofeng Sun et al. GASTROENTEROLOGY
- Chemokine–chemokine receptors in cancer immunotherapy
- (2010) Trina J Stewart et al. Immunotherapy
- Adenosine and Prostaglandin E2Cooperate in the Suppression of Immune Responses Mediated by Adaptive Regulatory T Cells
- (2010) Magis Mandapathil et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Distinct Roles of Adenylyl Cyclase VII in Regulating the Immune Responses in Mice
- (2010) B. Duan et al. JOURNAL OF IMMUNOLOGY
- Extracellular adenosine triphosphate and adenosine in cancer
- (2010) J Stagg et al. ONCOGENE
- Anti-CD73 antibody therapy inhibits breast tumor growth and metastasis
- (2010) J. Stagg et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Development of Ipilimumab: Contribution to a New Paradigm for Cancer Immunotherapy
- (2010) Axel Hoos et al. SEMINARS IN ONCOLOGY
- Arginase I–Producing Myeloid-Derived Suppressor Cells in Renal Cell Carcinoma Are a Subpopulation of Activated Granulocytes
- (2009) Paulo C. Rodriguez et al. CANCER RESEARCH
- HIF-dependent induction of adenosine receptor A2b skews human dendritic cells to a Th2-stimulating phenotype under hypoxia
- (2009) Meixiang Yang et al. IMMUNOLOGY AND CELL BIOLOGY
- Human Follicular Lymphoma CD39+-Infiltrating T Cells Contribute to Adenosine-Mediated T Cell Hyporesponsiveness
- (2009) S. P. Hilchey et al. JOURNAL OF IMMUNOLOGY
- Discovery of Potent Competitive Inhibitors of Indoleamine 2,3-Dioxygenase with in Vivo Pharmacodynamic Activity and Efficacy in a Mouse Melanoma Model
- (2009) Eddy W. Yue et al. JOURNAL OF MEDICINAL CHEMISTRY
- NF546 [4,4'-(Carbonylbis(imino-3,1-phenylene-carbonylimino-3,1-(4-methyl-phenylene)-carbonylimino))-bis(1,3-xylene- , '-diphosphonic Acid) Tetrasodium Salt] Is a Non-Nucleotide P2Y11 Agonist and Stimulates Release of Interleukin-8 from Human Monocyte-Derived Dendritic Cells
- (2009) S. Meis et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Activation of the NLRP3 inflammasome in dendritic cells induces IL-1β–dependent adaptive immunity against tumors
- (2009) François Ghiringhelli et al. NATURE MEDICINE
- P2X7: a growth-promoting receptor—implications for cancer
- (2009) Francesco Di Virgilio et al. Purinergic Signalling
- T regulatory cells: hypoxia-adenosinergic suppression and re-direction of the immune response
- (2009) Michail V. Sitkovsky TRENDS IN IMMUNOLOGY
- TGF-β and kynurenines as the key to infectious tolerance
- (2009) Maria L. Belladonna et al. TRENDS IN MOLECULAR MEDICINE
- Increased circulating myeloid-derived suppressor cells correlate with clinical cancer stage, metastatic tumor burden, and doxorubicin–cyclophosphamide chemotherapy
- (2008) C. Marcela Diaz-Montero et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Cyclooxygenase-2 Expression Is an Independent Predictor of Poor Prognosis in Colon Cancer
- (2008) S. Ogino et al. CLINICAL CANCER RESEARCH
- Regulation of cAMP Responses by the G12/13 Pathway Converges on Adenylyl Cyclase VII
- (2008) Lily I. Jiang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Anti-Inflammatory, Antiproliferative, and Cytoprotective Activity of NO Chimera Nitrates of Use in Cancer Chemoprevention
- (2008) G. K. Hagos et al. MOLECULAR PHARMACOLOGY
- NK cells and cancer immunosurveillance
- (2008) I Waldhauer et al. ONCOGENE
- Progress in the discovery of selective, high affinity A2B adenosine receptor antagonists as clinical candidates
- (2008) Rao V. Kalla et al. Purinergic Signalling
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started